A Risk Sciences International glossary definition
risk factors
« Back to Glossary Index
In the realm of epidemiology, finance, and other fields, “risk factors” refer to variables or conditions that increase the likelihood of a particular outcome or event occurring. These factors can be intrinsic or extrinsic and are often used in predictive models to assess probabilities. In healthcare, for example, a risk factor like high blood pressure may elevate the chance of heart disease. In finance, market volatility could be a risk factor for investment loss. Understanding risk factors allows for more informed decision-making and targeted interventions.
Related Articles:
- RSI and Engineers Canada develop on-line training courses
- RSI launches Global Risk Census
- Patricia LarkinDr. Larkin serves as an Associate Expert at Risk Sciences International, specializing in policy, regulatory analysis, and population health risk assessment. Her work with RSI has included life cycle assessments of metals, as well as a review of Alberta’s Water Cytotoxicity Testing Program. She contributes rigorous, equity-sensitive approaches to risk analysis, and brings a nuanced understanding of the intersections between policy, science, and public values.
- RSI paper on Manganese PBPK selected as a top 2017 paper
- RSI speaks to The Weather Network about wildfires and climate
- Decision making framework developed for Canadian Blood Services (CBS) now online
- IAI climate change report
- Quinolones and risk of retinal detachment
- Ila CoteDr. Cote is an Associate Expert at Risk Sciences International, where she brings world-class expertise in environmental health risk assessment, risk management, and science-informed public policy. She contributes to projects that require strategic application of risk methodologies to environmental, occupational, and chemical exposure issues—often at the intersection of regulation, sustainability, and health protection. Her work with RSI benefits from her deep understanding of both U.S. and international regulatory environments and her commitment to advancing decision-making through transparent and defensible science.
- Risk of Myocarditis and Pericarditis
- Training Seminar in Systematic Review
- Paul PriceDr. Paul Price is a Senior Analyst at Risk Sciences International (RSI), bringing over four decades of experience as a pioneer in exposure science and chemical risk assessment. Since joining RSI in 2019, Dr. Price has focused on advancing mixture risk assessment—an increasingly vital area as regulators shift from assessing single chemicals in isolation to understanding the cumulative effects of combined exposures. His current work includes the development of Mixture Adjustment Factors, participation in international regulatory committees, and authorship of scholarly publications aimed at refining the science-policy interface of chemical mixture risk.
- Safety Profiles of Newer Contraceptives presented at meeting of Society of Reproductive Investigation
- Principles of risk decision-makingRSI investigators propose fundamental principles of risk decision-making, and explore their application in a range of real-world risk decision-making contexts. These ten principles will provide valuable guidance on addressing current and future risk issues facing civil societies worldwide.
- Stones
- Value of information analysis framework
- Food safety assessments
- Evidence-based Risk Assessment Framework
- Dr. Emma Hartnett Selected for JEMRA Roster of Scientific Experts
- Mustafa Al-ZoughoolDr. Al-Zoughool has maintained a long-standing relationship with Risk Sciences International, both as a scientific collaborator and as a co-investigator on complex international projects. His work with RSI focuses on high-level public health risk modeling, mechanistic data analysis, and toxicological risk assessment of major environmental contaminants in air, soil, and water, including formaldehyde, lead, and 1,4-dioxane. His research also extends to methodological innovation and the development of evidence-based strategies for environmental and occupational health policy.
- Risks of anticholinergic drugs
- Best Practices for Consideration of the Effects of Climate Change in Project-Level Assessments
- QuarterWatch analyzes MedWatch Reports
- Shintaro HagiwaraDr. Shintaro Hagiwara is a Risk Analyst and Statistician at Risk Sciences International (RSI), where he contributes cutting-edge statistical insight to risk assessments, particularly in chemical safety and public health. Since joining RSI’s technical team in 2018 and transitioning to a full-time role in 2023, he has applied his deep quantitative knowledge to building theoretical foundations and developing statistical software. Notably, he created the database-calibrated assessment process (DCAP) and the enhanced value-of-information (VOI) framework to aid in evidence-based regulatory decision-making, both of which have been reviewed by the Board of Scientific Counselors (BOSC). His applied statistical work provides assessments and tools to derive PODs for chemicals such as inorganic arsenic and fluoride to support both Canadian and international regulatory bodies.
- RSI – Risk Sciences International
Categories: scientific and technical
« Back to Glossary Index